PP_1170x120_10-25-21

antibiotic

Aurobindo launches generic of Suprax

DAYTON, N.J. — Aurobindo Pharma Ltd. has received the first Abbreviated New Drug Application approval from the Food and Drug Administration for cefixime for oral suspension, USP, 100 mg/5 ml and 200 mg/5 ml. Cefixime for O.S. is bioequivalent and therapeutically equivalent to Suprax from Lupin Pharmaceuticals Inc. It is indicated for the treatment of